Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-109401
Filing Date
2025-08-15
Accepted
2025-08-15 16:19:37
Documents
1
Period of Report
2025-04-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2088
  Complete submission text file 0000950170-25-109401.txt   3767
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Issuer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O ATOSSA GENETICS INC. 1616 EASTLAKE AVE. E SUITE 510 SEATTLE WA 98102
Business Address
Guse Kyle (Reporting) CIK: 0001566618 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34375 | Film No.: 251224906